Abstract
The 5-year survival rates for childhood ALL are approaching 80%, but therapy-related toxicities are common. One of the challenges in this population is determining the most efficacious therapeutic regimens for these individuals. Factors such as drug metabolism, genetics, and concomitant disease affect drug efficacy and may be important in determining therapeutic outcomes in these patients. This review will focus on these factors in the treatment of childhood ALL.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 320-326 |
| Number of pages | 7 |
| Journal | Pediatric Blood and Cancer |
| Volume | 51 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ALL
- Pediatric oncology
- Pharmacology
Fingerprint
Dive into the research topics of 'Host factors and consequence of chemotherapy in pediatric cancer patients'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS